本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 山东东方海洋科技股份有限公司（以下简称"公司"或"本公司"）于 2025 年 9 月 30 日召开第八届董事会第二十四次会议审议通过了《关于召开 2025 年第一次 临时股东会的议案》，董事会定于 2025 年 10 月 24 日（星期五）上午 09:30 召 开公司 2025 年第一次临时股东会。会议相关事项通知如下： 一、召开会议的基本情况 证券代码：002086 证券简称：东方海洋 公告编号：2025-054 山东东方海洋科技股份有限公司 关于召开 2025 年第一次临时股东会的通知 1、股东会届次：2025 年第一次临时股东会。 2、股东会的召集人：公司董事会。 3、会议召开的合法、合规性：本次股东会审议事项属于公司股东会职权范 围，审议事项合法、完备，不违反相关法律、法规和《公司章程》的规定。相关 议案已经于 2025 年 9 月 30 日召开的公司第八届董事会第二十四次会议、第八届 监事会第十三次会议审议通过。本次股东会的召集、召开程序符合《中华人民共 和国公司法》《上市公司股东会规则》等有关法律、行 ...

该议案尚需提交股东会审议，公司第八届监事会及各位监事仍应严格按照法 律法规及《公司章程》的规定继续尽职履责。公司监事任职期间恪尽职守、勤勉 尽责，公司对各位监事在任职期间对公司治理及发展作出的贡献表示衷心感谢！ 证券代码：002086 证券简称：东方海洋 公告编号：2025-055 山东东方海洋科技股份有限公司 第八届监事会第十三次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 山东东方海洋科技股份有限公司（以下简称"公司"）第八届监事会第十三次会 议于 2025 年 9 月 24 日以电话、邮件等形式通知全体监事，会议定于 2025 年 9 月 30 日上午以通讯方式召开，会议应到监事 5 人，实际参加及审议监事 5 人，会议 由监事会主席王顺奎先生召集并主持。本次会议的召集、召开符合《公司法》和 《公司章程》的有关规定。会议以通讯表决方式审议并通过如下决议： 一、审议通过《关于修订<公司章程>的议案》 根据《中华人民共和国公司法》《关于新<公司法>配套制度规则实施相关过渡 期安排》《上市公司章程指引》《深圳证券交易所股票上市规则》等有关法律法 ...

证券代码：002086 证券简称：东方海洋 公告编号：2025-056 表决结果：同意票 8 票，反对票 0 票，弃权票 0 票。 本议案尚需提交公司 2025 年第一次临时股东会审议，并提请股东会授权公司 管理层办理相应的工商变更登记事宜。 二、逐项审议通过《关于修订公司部分治理制度的议案》 山东东方海洋科技股份有限公司 第八届董事会第二十四次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 山东东方海洋科技股份有限公司（以下简称"公司"）第八届董事会第二十四次 会议于 2025 年 9 月 24 日以电话、邮件等形式通知全体董事，会议定于 2025 年 9 月 30 日以通讯方式召开，应参加董事 8 人，实际参加审议及表决董事 8 人。会议 的召集、召开符合《公司法》和《公司章程》规定，会议由董事长（代行）刘洪涛 先生召集并主持。会议以通讯表决方式通过以下议案： 一、审议通过《关于修订<公司章程>的议案》； 经审核，董事会认为：根据《公司法》《证券法》《上市公司章程指引》《深 圳证券交易所股票上市规则》等法律法规及规范性文件的要求，公司拟对《公 ...

Group 1: Company Announcements - Ganli Pharmaceutical signed a technology transfer and supply agreement with FZ and BIOMM, with a total supply framework agreement amount expected to be no less than 3 billion RMB [1] - Upwind New Materials completed the transfer of 121 million shares, changing its controlling shareholder to Zhiyuan Hengyue, associated with Zhiyuan Robotics [2] - Poly Developments plans to publicly issue corporate bonds not exceeding 15 billion RMB for various purposes including debt repayment and project construction [3] Group 2: Shareholder Actions - Lenovo Holdings reduced its stake in Lakala by 8.0781 million shares, decreasing its ownership from 25.00% to 23.97% [4] - Fenghuo Communication plans to repurchase shares with a budget between 75 million and 150 million RMB, with a maximum repurchase price of 40.53 RMB per share [5] - Hualing Cable intends to acquire control of San Bamboo Intelligent for no more than 270 million RMB to enhance its capabilities in robotics and high-frequency transmission [6] Group 3: Market Developments - Guiguang Network clarified that rumors regarding major collaborations with Huawei Cloud and restructuring with state-owned enterprises are untrue [7] - Dongshan Precision is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its international presence [8] - Wolong Nuclear Materials' subsidiary plans to invest up to 1 billion RMB in a new materials project in Suzhou [9] Group 4: Other Corporate Activities - Chao Xun Communication's management completed their share reduction plan, with specific shares sold by board members [10] - Various companies are involved in significant project bids and collaborations, including China Electric Research and others [15]

Group 1 - The core transaction on September 23 involved a volume of 19.48 million shares and a transaction amount of 50.65 million yuan, with a transaction price of 2.60 yuan per share [2][3] - The buyer was China International Capital Corporation Wealth Securities Co., Ltd., Yantai Huanghai Road Securities Branch, and the seller was Huatai Securities Co., Ltd., Shaoxing Fushan Securities Branch [2] - In the last three months, the stock has seen a total of six block trades, amounting to a cumulative transaction value of 107 million yuan [3] Group 2 - On the same day, the closing price of Dongfang Ocean was 2.60 yuan, reflecting a decline of 2.62%, with a turnover rate of 3.38% and a total transaction amount of 138 million yuan [3] - The stock experienced a net outflow of 17.15 million yuan in main capital for the day, and over the past five days, it has cumulatively declined by 8.77% with a total capital outflow of 107 million yuan [3] - Shandong Dongfang Ocean Technology Co., Ltd. was established on December 19, 2001, with a registered capital of 1.9589465 billion yuan [3]

Core Viewpoint - Dongfang Ocean (002086.SZ) announced that its subsidiary, Mass Spectrometry Biotechnology Co., Ltd., has received registration approval from the Shandong Provincial Drug Administration for its self-developed fat-soluble vitamin testing kit, which utilizes liquid chromatography-tandem mass spectrometry. This product is now approved for market launch, enhancing the product line in the clinical testing field [1] Company Summary - The newly approved product will enrich the product offerings of Mass Spectrometry Biotechnology Co., Ltd. in the clinical testing sector [1] - Despite the product's approval, it is noted that the impact on the company's performance this year is minimal, indicating uncertainty regarding the future financial contributions of this product [1]

本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或者重大遗漏。 特别提示： 1. 质谱生物科技有限公司今年对公司的业绩影响较小，本次获批上市的脂 溶性维生素测定试剂盒（液相色谱—串联质谱法）的投产及对公司业绩的后续影 响具有不确定性，请广大投资者注意投资风险。 2. 本次产品获证后还未投入生产，其实际销售情况受市场拓展力度及市场 实际需求等多重因素影响，目前尚无法预测上述获批产品对公司未来业绩的具体 影响，请广大投资者注意投资风险。 请广大投资者充分阅读本公告正文表述的相关风险事项，公司特别提示投资 者理性投资。 证券代码：002086 证券简称：东方海洋 公告编号：2025-052 山东东方海洋科技股份有限公司（以下简称"公司"）子公司质谱生物科技有 限公司自主研发的脂溶性维生素测定试剂盒（液相色谱—串联质谱法）于近日取 得了山东省药品监督管理局的注册批准，获得医疗器械注册证（体外诊断试剂）， 具体情况如下： 山东东方海洋科技股份有限公司 关于子公司取得医疗器械注册证的公告 同时，上述产品获证后还未投入生产，其实际销售情况受市场拓展力度及市 场实际需求等多重因素影响，目前 ...

Group 1 - The core point of the article is that Shandong Oriental Ocean Technology Co., Ltd.'s subsidiary, Mass Spectrometry Biotechnology Co., Ltd., has received registration approval from the Shandong Provincial Drug Administration for its self-developed fat-soluble vitamin testing kit, which is now officially recognized as a medical device [1] Group 2 - The product is named "Fat-Soluble Vitamin Testing Kit" and has recently obtained the medical device registration certificate [1]

Core Viewpoint - Dongfang Ocean (002086.SZ) announced that its subsidiary, Mass Spectrometry Biotechnology Co., Ltd., has received registration approval from the Shandong Provincial Drug Administration for its self-developed fat-soluble vitamin testing kit, which utilizes liquid chromatography-tandem mass spectrometry [1] Company Summary - The approved product will enhance the product line of Mass Spectrometry Biotechnology Co., Ltd. in the clinical testing field [1] - Despite the new product approval, the impact on the company's performance this year is expected to be minimal, indicating uncertainty regarding the future financial contributions of this product [1]

9月23日，东方海洋大宗交易成交1948.1万股，成交额5065.06万元，占当日总成交额的26.78%，成交价 2.6元，较市场收盘价2.6元持平。 ...